ID DANi011-A AC CVCL_XJ28 SY DANi-011A; LRRK2-011-C1 DR BioSamples; SAMEA5912483 DR hPSCreg; DANi011-A DR Wikidata; Q93503263 RX PubMed=32305865; CC From: Danish Research Institute of Translational Neuroscience, Aarhus University; Aarhus; Denmark. CC Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PubMed=32305865). CC Derived from site: In situ; Skin; UBERON=UBERON_0002097. CC Cell type: Fibroblast of skin; CL=CL_0002620. ST Source(s): PubMed=32305865 ST Amelogenin: X ST CSF1PO: 10,13 ST D13S317: 9,13 ST D16S539: 9,12 ST D21S11: 27,32.2 ST D5S818: 10,12 ST D7S820: 9,10 ST TH01: 9.3 ST TPOX: 8,11 ST vWA: 17 DI NCIt; C198605; Parkinson disease 8, autosomal dominant DI ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease OX NCBI_TaxID=9606; ! Homo sapiens (Human) SX Female AG 70Y CA Induced pluripotent stem cell DT Created: 19-12-19; Last updated: 19-12-24; Version: 8 // RX PubMed=32305865; DOI=10.1016/j.scr.2020.101781; RA Chen M., Maimaitili M., Buchholdt S.H., Jensen U.B., Febbraro F., RA Denham M.; RT "Generation of an induced pluripotent stem cell line (DANi-011A) from RT a Parkinson's disease patient with a LRRK2 p.G2019S mutation."; RL Stem Cell Res. 45:101781-101781(2020). //